0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global β-Nicotinamide Mononucleotide (NMN) Market Research Report 2026
Published Date: 2026-03-30
|
Report Code: QYRE-Auto-16K9169
Home | Market Reports
Global β Nicotinamide Mononucleotide NMN Market Insights and Forecast to 2028
BUY CHAPTERS

Global β-Nicotinamide Mononucleotide (NMN) Market Research Report 2026

Code: QYRE-Auto-16K9169
Report
2026-03-30
Pages:135
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

β-Nicotinamide Mononucleotide (NMN) Market Size

The global β-Nicotinamide Mononucleotide (NMN) market was valued at US$ 468 million in 2025 and is anticipated to reach US$ 1112 million by 2032, at a CAGR of 13.4% from 2026 to 2032.

β-Nicotinamide Mononucleotide (NMN) Market

β-Nicotinamide Mononucleotide (NMN) Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on β-Nicotinamide Mononucleotide (NMN) competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Nicotinamide mononucleotide (NMN) is an intermediate of NAD+ biosynthesis produced from nicotinamide through nicotinamide phosphoribosyltransferase (NAMPT) and also referred to as NMN or nicotinamide ribotide. In recent studies of NMN applications to prevention and diagnosis of age-dependent diseases such as diabetes, neurodegenerative disorder, cardiac disease etc., it has become one of hottest biomarkers on discussion for anti-aging, lately.
NMN is a precursor of nicotinamide adenine dinucleotide (NAD+), which plays a vital role in cell metabolism and energy production. As we age, the level of NAD+ in the human body gradually decreases, resulting in weakened cell metabolism, which in turn triggers a series of aging-related diseases. Therefore, increasing the level of NAD+ in the body by supplementing NMN has become a new way to fight aging and maintain good health.
With the general improvement of global health awareness and continuous breakthroughs in scientific research and technology, the growth momentum of the NMN market will continue to increase. In the future, the NMN market will achieve a deeper cross-border integration with other health industries such as biotechnology, precision medicine, and nutritional supplements, giving rise to a series of innovative products and service models to meet consumers' more personalized and precise health needs.
At present, nicotinamide mononucleotide (NMN) is still in the development stage. There are not many manufacturers in the global market, and consumers have weak awareness of its use, especially in developing countries. The demand is lower than that in developed countries around the world, but the demand in developing countries is growing rapidly. Leading giants have proposed expansion plans and increased production bases.
Nicotinamide mononucleotide (NMN) core manufacturers include GeneHarbor, Mirailab Bioscience, Maac10 Formulas, Herbalmax and Genex Formula. China is the largest production area, accounting for about 84% of the global market share, followed by North America and Japan. The downstream applications of nicotinamide mononucleotide include health products, cosmetics, etc. Globally, health products are the largest application market, and raw materials for health products account for 99% of the total sales of nicotinamide mononucleotide in 2023.
This report delivers a comprehensive overview of the global β-Nicotinamide Mononucleotide (NMN) market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding β-Nicotinamide Mononucleotide (NMN). The β-Nicotinamide Mononucleotide (NMN) market size, estimates, and forecasts are provided in terms of shipments (Tons) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global β-Nicotinamide Mononucleotide (NMN) market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist β-Nicotinamide Mononucleotide (NMN) manufacturers, new entrants, and companies across the industry value chain with information on revenues, production, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of β-Nicotinamide Mononucleotide (NMN) Market Report

Report Metric Details
Report Name β-Nicotinamide Mononucleotide (NMN) Market
Accounted market size in 2025 US$ 468 million
Forecasted market size in 2032 US$ 1112 million
CAGR 13.4%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • Content ≥98%
  • Content <98%
by Application
  • Health Care Products
  • Cosmetics
  • Others
Production by Region
  • North America
  • China
  • Japan
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company GeneHarbor, Herbalmax, Genex Formulas, Mirailab Bioscience, Maac10 Formulas, EffePharm, Bontac, CELFULL, Kingdomway, ABA Chemical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for β-Nicotinamide Mononucleotide (NMN) manufacturers, including prices, production, value-based market shares, latest development plans, and information on mergers and acquisitions.
  • Chapter 3: Examines β-Nicotinamide Mononucleotide (NMN) production/output and value by region and country, providing a quantitative assessment of market size and growth potential for each region over the next six years.
  • Chapter 4: Analyzes β-Nicotinamide Mononucleotide (NMN) consumption at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national production.
  • Chapter 5: Analyzes market segments by Type, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 6: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 7: Profiles key players, detailing the fundamentals of major companies, including product production/output, value, price, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 8: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 9: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 10: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is β-Nicotinamide Mononucleotide (NMN) Market growing?

Ans: The β-Nicotinamide Mononucleotide (NMN) Market witnessing a CAGR of 13.4% during the forecast period 2026-2032.

What is the β-Nicotinamide Mononucleotide (NMN) Market size in 2032?

Ans: The β-Nicotinamide Mononucleotide (NMN) Market size in 2032 will be US$ 1112 million.

What is the β-Nicotinamide Mononucleotide (NMN) Market production share by region?

Ans: China is the largest production area, accounting for about 84% of the global market share, followed by North America and Japan.

Who are the main players in the β-Nicotinamide Mononucleotide (NMN) Market report?

Ans: The main players in the β-Nicotinamide Mononucleotide (NMN) Market are GeneHarbor, Herbalmax, Genex Formulas, Mirailab Bioscience, Maac10 Formulas, EffePharm, Bontac, CELFULL, Kingdomway, ABA Chemical

What are the Application segmentation covered in the β-Nicotinamide Mononucleotide (NMN) Market report?

Ans: The Applications covered in the β-Nicotinamide Mononucleotide (NMN) Market report are Health Care Products, Cosmetics, Others

What are the Type segmentation covered in the β-Nicotinamide Mononucleotide (NMN) Market report?

Ans: The Types covered in the β-Nicotinamide Mononucleotide (NMN) Market report are Content ≥98%, Content <98%

1 β-Nicotinamide Mononucleotide (NMN) Market Overview
1.1 Product Definition
1.2 β-Nicotinamide Mononucleotide (NMN) by Type
1.2.1 Global β-Nicotinamide Mononucleotide (NMN) Market Value Growth Rate Analysis by Type: 2025 vs 2032
1.2.2 Content ≥98%
1.2.3 Content <98%
1.3 β-Nicotinamide Mononucleotide (NMN) by Application
1.3.1 Global β-Nicotinamide Mononucleotide (NMN) Market Value Growth Rate Analysis by Application: 2025 vs 2032
1.3.2 Health Care Products
1.3.3 Cosmetics
1.3.4 Others
1.4 Global Market Growth Prospects
1.4.1 Global β-Nicotinamide Mononucleotide (NMN) Production Value Estimates and Forecasts (2021–2032)
1.4.2 Global β-Nicotinamide Mononucleotide (NMN) Production Capacity Estimates and Forecasts (2021–2032)
1.4.3 Global β-Nicotinamide Mononucleotide (NMN) Production Estimates and Forecasts (2021–2032)
1.4.4 Global β-Nicotinamide Mononucleotide (NMN) Market Average Price Estimates and Forecasts (2021–2032)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global β-Nicotinamide Mononucleotide (NMN) Production Market Share by Manufacturers (2021–2026)
2.2 Global β-Nicotinamide Mononucleotide (NMN) Production Value Market Share by Manufacturers (2021–2026)
2.3 Global Key Players of β-Nicotinamide Mononucleotide (NMN), Industry Ranking, 2024 vs 2025
2.4 Global β-Nicotinamide Mononucleotide (NMN) Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.5 Global β-Nicotinamide Mononucleotide (NMN) Average Price by Manufacturers (2021–2026)
2.6 Global Key Manufacturers of β-Nicotinamide Mononucleotide (NMN), Manufacturing Footprints and Headquarters
2.7 Global Key Manufacturers of β-Nicotinamide Mononucleotide (NMN), Product Offerings and Applications
2.8 Global Key Manufacturers of β-Nicotinamide Mononucleotide (NMN), Date of Entry into the Industry
2.9 β-Nicotinamide Mononucleotide (NMN) Market Competitive Situation and Trends
2.9.1 β-Nicotinamide Mononucleotide (NMN) Market Concentration Rate
2.9.2 Top 5 and Top 10 Global β-Nicotinamide Mononucleotide (NMN) Players Market Share by Revenue
2.10 Mergers & Acquisitions and Expansion
3 β-Nicotinamide Mononucleotide (NMN) Production by Region
3.1 Global β-Nicotinamide Mononucleotide (NMN) Production Value Estimates and Forecasts by Region: 2021 vs 2025 vs 2032
3.2 Global β-Nicotinamide Mononucleotide (NMN) Production Value by Region (2021–2032)
3.2.1 Global β-Nicotinamide Mononucleotide (NMN) Production Value by Region (2021–2026)
3.2.2 Global Forecasted Production Value of β-Nicotinamide Mononucleotide (NMN) by Region (2027–2032)
3.3 Global β-Nicotinamide Mononucleotide (NMN) Production Estimates and Forecasts by Region: 2021 vs 2025 vs 2032
3.4 Global β-Nicotinamide Mononucleotide (NMN) Production Volume by Region (2021–2032)
3.4.1 Global β-Nicotinamide Mononucleotide (NMN) Production by Region (2021–2026)
3.4.2 Global Forecasted Production of β-Nicotinamide Mononucleotide (NMN) by Region (2027–2032)
3.5 Global β-Nicotinamide Mononucleotide (NMN) Market Price Analysis by Region (2021–2026)
3.6 Global β-Nicotinamide Mononucleotide (NMN) Production, Value, and Year-over-Year Growth
3.6.1 North America β-Nicotinamide Mononucleotide (NMN) Production Value Estimates and Forecasts (2021–2032)
3.6.2 China β-Nicotinamide Mononucleotide (NMN) Production Value Estimates and Forecasts (2021–2032)
3.6.3 Japan β-Nicotinamide Mononucleotide (NMN) Production Value Estimates and Forecasts (2021–2032)
4 β-Nicotinamide Mononucleotide (NMN) Consumption by Region
4.1 Global β-Nicotinamide Mononucleotide (NMN) Consumption Estimates and Forecasts by Region: 2021 vs 2025 vs 2032
4.2 Global β-Nicotinamide Mononucleotide (NMN) Consumption by Region (2021–2032)
4.2.1 Global β-Nicotinamide Mononucleotide (NMN) Consumption by Region (2021–2026)
4.2.2 Global β-Nicotinamide Mononucleotide (NMN) Forecasted Consumption by Region (2027–2032)
4.3 North America
4.3.1 North America β-Nicotinamide Mononucleotide (NMN) Consumption Growth Rate by Country: 2021 vs 2025 vs 2032
4.3.2 North America β-Nicotinamide Mononucleotide (NMN) Consumption by Country (2021–2032)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe β-Nicotinamide Mononucleotide (NMN) Consumption Growth Rate by Country: 2021 vs 2025 vs 2032
4.4.2 Europe β-Nicotinamide Mononucleotide (NMN) Consumption by Country (2021–2032)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific β-Nicotinamide Mononucleotide (NMN) Consumption Growth Rate by Region: 2021 vs 2025 vs 2032
4.5.2 Asia Pacific β-Nicotinamide Mononucleotide (NMN) Consumption by Region (2021–2032)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa β-Nicotinamide Mononucleotide (NMN) Consumption Growth Rate by Country: 2021 vs 2025 vs 2032
4.6.2 Latin America, Middle East & Africa β-Nicotinamide Mononucleotide (NMN) Consumption by Country (2021–2032)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
4.6.6 GCC Countries
5 Segment by Type
5.1 Global β-Nicotinamide Mononucleotide (NMN) Production by Type (2021–2032)
5.1.1 Global β-Nicotinamide Mononucleotide (NMN) Production by Type (2021–2026)
5.1.2 Global β-Nicotinamide Mononucleotide (NMN) Production by Type (2027–2032)
5.1.3 Global β-Nicotinamide Mononucleotide (NMN) Production Market Share by Type (2021–2032)
5.2 Global β-Nicotinamide Mononucleotide (NMN) Production Value by Type (2021–2032)
5.2.1 Global β-Nicotinamide Mononucleotide (NMN) Production Value by Type (2021–2026)
5.2.2 Global β-Nicotinamide Mononucleotide (NMN) Production Value by Type (2027–2032)
5.2.3 Global β-Nicotinamide Mononucleotide (NMN) Production Value Market Share by Type (2021–2032)
5.3 Global β-Nicotinamide Mononucleotide (NMN) Price by Type (2021–2032)
6 Segment by Application
6.1 Global β-Nicotinamide Mononucleotide (NMN) Production by Application (2021–2032)
6.1.1 Global β-Nicotinamide Mononucleotide (NMN) Production by Application (2021–2026)
6.1.2 Global β-Nicotinamide Mononucleotide (NMN) Production by Application (2027–2032)
6.1.3 Global β-Nicotinamide Mononucleotide (NMN) Production Market Share by Application (2021–2032)
6.2 Global β-Nicotinamide Mononucleotide (NMN) Production Value by Application (2021–2032)
6.2.1 Global β-Nicotinamide Mononucleotide (NMN) Production Value by Application (2021–2026)
6.2.2 Global β-Nicotinamide Mononucleotide (NMN) Production Value by Application (2027–2032)
6.2.3 Global β-Nicotinamide Mononucleotide (NMN) Production Value Market Share by Application (2021–2032)
6.3 Global β-Nicotinamide Mononucleotide (NMN) Price by Application (2021–2032)
7 Key Companies Profiled
7.1 GeneHarbor
7.1.1 GeneHarbor β-Nicotinamide Mononucleotide (NMN) Company Information
7.1.2 GeneHarbor β-Nicotinamide Mononucleotide (NMN) Product Portfolio
7.1.3 GeneHarbor β-Nicotinamide Mononucleotide (NMN) Production, Value, Price, and Gross Margin (2021–2026)
7.1.4 GeneHarbor Main Business and Markets Served
7.1.5 GeneHarbor Recent Developments/Updates
7.2 Herbalmax
7.2.1 Herbalmax β-Nicotinamide Mononucleotide (NMN) Company Information
7.2.2 Herbalmax β-Nicotinamide Mononucleotide (NMN) Product Portfolio
7.2.3 Herbalmax β-Nicotinamide Mononucleotide (NMN) Production, Value, Price, and Gross Margin (2021–2026)
7.2.4 Herbalmax Main Business and Markets Served
7.2.5 Herbalmax Recent Developments/Updates
7.3 Genex Formulas
7.3.1 Genex Formulas β-Nicotinamide Mononucleotide (NMN) Company Information
7.3.2 Genex Formulas β-Nicotinamide Mononucleotide (NMN) Product Portfolio
7.3.3 Genex Formulas β-Nicotinamide Mononucleotide (NMN) Production, Value, Price, and Gross Margin (2021–2026)
7.3.4 Genex Formulas Main Business and Markets Served
7.3.5 Genex Formulas Recent Developments/Updates
7.4 Mirailab Bioscience
7.4.1 Mirailab Bioscience β-Nicotinamide Mononucleotide (NMN) Company Information
7.4.2 Mirailab Bioscience β-Nicotinamide Mononucleotide (NMN) Product Portfolio
7.4.3 Mirailab Bioscience β-Nicotinamide Mononucleotide (NMN) Production, Value, Price, and Gross Margin (2021–2026)
7.4.4 Mirailab Bioscience Main Business and Markets Served
7.4.5 Mirailab Bioscience Recent Developments/Updates
7.5 Maac10 Formulas
7.5.1 Maac10 Formulas β-Nicotinamide Mononucleotide (NMN) Company Information
7.5.2 Maac10 Formulas β-Nicotinamide Mononucleotide (NMN) Product Portfolio
7.5.3 Maac10 Formulas β-Nicotinamide Mononucleotide (NMN) Production, Value, Price, and Gross Margin (2021–2026)
7.5.4 Maac10 Formulas Main Business and Markets Served
7.5.5 Maac10 Formulas Recent Developments/Updates
7.6 EffePharm
7.6.1 EffePharm β-Nicotinamide Mononucleotide (NMN) Company Information
7.6.2 EffePharm β-Nicotinamide Mononucleotide (NMN) Product Portfolio
7.6.3 EffePharm β-Nicotinamide Mononucleotide (NMN) Production, Value, Price, and Gross Margin (2021–2026)
7.6.4 EffePharm Main Business and Markets Served
7.6.5 EffePharm Recent Developments/Updates
7.7 Bontac
7.7.1 Bontac β-Nicotinamide Mononucleotide (NMN) Company Information
7.7.2 Bontac β-Nicotinamide Mononucleotide (NMN) Product Portfolio
7.7.3 Bontac β-Nicotinamide Mononucleotide (NMN) Production, Value, Price, and Gross Margin (2021–2026)
7.7.4 Bontac Main Business and Markets Served
7.7.5 Bontac Recent Developments/Updates
7.8 CELFULL
7.8.1 CELFULL β-Nicotinamide Mononucleotide (NMN) Company Information
7.8.2 CELFULL β-Nicotinamide Mononucleotide (NMN) Product Portfolio
7.8.3 CELFULL β-Nicotinamide Mononucleotide (NMN) Production, Value, Price, and Gross Margin (2021–2026)
7.8.4 CELFULL Main Business and Markets Served
7.8.5 CELFULL Recent Developments/Updates
7.9 Kingdomway
7.9.1 Kingdomway β-Nicotinamide Mononucleotide (NMN) Company Information
7.9.2 Kingdomway β-Nicotinamide Mononucleotide (NMN) Product Portfolio
7.9.3 Kingdomway β-Nicotinamide Mononucleotide (NMN) Production, Value, Price, and Gross Margin (2021–2026)
7.9.4 Kingdomway Main Business and Markets Served
7.9.5 Kingdomway Recent Developments/Updates
7.10 ABA Chemical
7.10.1 ABA Chemical β-Nicotinamide Mononucleotide (NMN) Company Information
7.10.2 ABA Chemical β-Nicotinamide Mononucleotide (NMN) Product Portfolio
7.10.3 ABA Chemical β-Nicotinamide Mononucleotide (NMN) Production, Value, Price, and Gross Margin (2021–2026)
7.10.4 ABA Chemical Main Business and Markets Served
7.10.5 ABA Chemical Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 β-Nicotinamide Mononucleotide (NMN) Industry Chain Analysis
8.2 β-Nicotinamide Mononucleotide (NMN) Raw Material Supply Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 β-Nicotinamide Mononucleotide (NMN) Production Modes and Processes
8.4 β-Nicotinamide Mononucleotide (NMN) Sales and Marketing
8.4.1 β-Nicotinamide Mononucleotide (NMN) Sales Channels
8.4.2 β-Nicotinamide Mononucleotide (NMN) Distributors
8.5 β-Nicotinamide Mononucleotide (NMN) Customer Analysis
9 β-Nicotinamide Mononucleotide (NMN) Market Dynamics
9.1 β-Nicotinamide Mononucleotide (NMN) Industry Trends
9.2 β-Nicotinamide Mononucleotide (NMN) Market Drivers
9.3 β-Nicotinamide Mononucleotide (NMN) Market Challenges
9.4 β-Nicotinamide Mononucleotide (NMN) Market Restraints
9.5 Impact of U.S. Tariffs
10 Research Findings and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
List of Tables
 Table 1. Global β-Nicotinamide Mononucleotide (NMN) Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global β-Nicotinamide Mononucleotide (NMN) Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global β-Nicotinamide Mononucleotide (NMN) Production Capacity (Tons) by Manufacturers in 2025
 Table 4. Global β-Nicotinamide Mononucleotide (NMN) Production by Manufacturers (Tons), 2021–2026
 Table 5. Global β-Nicotinamide Mononucleotide (NMN) Production Market Share by Manufacturers (2021–2026)
 Table 6. Global β-Nicotinamide Mononucleotide (NMN) Production Value by Manufacturers (US$ Million), 2021–2026
 Table 7. Global β-Nicotinamide Mononucleotide (NMN) Production Value Share by Manufacturers (2021–2026)
 Table 8. Global Key Players of β-Nicotinamide Mononucleotide (NMN), Industry Ranking, 2024 vs 2025
 Table 9. Classification of Companies by Tier (Tier 1, Tier 2, Tier 3), based on β-Nicotinamide Mononucleotide (NMN) Production Value, 2025
 Table 10. Global Market β-Nicotinamide Mononucleotide (NMN) Average Price by Manufacturers (US$/Kg), 2021–2026
 Table 11. Global Key Manufacturers of β-Nicotinamide Mononucleotide (NMN), Manufacturing Footprints and Headquarters
 Table 12. Global Key Manufacturers of β-Nicotinamide Mononucleotide (NMN), Product Offerings and Applications
 Table 13. Global Key Manufacturers of β-Nicotinamide Mononucleotide (NMN), Date of Entry into the Industry
 Table 14. Global β-Nicotinamide Mononucleotide (NMN) Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 15. Mergers & Acquisitions and Expansion Plans
 Table 16. Global β-Nicotinamide Mononucleotide (NMN) Production Value by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 17. Global β-Nicotinamide Mononucleotide (NMN) Production Value (US$ Million) by Region (2021–2026)
 Table 18. Global β-Nicotinamide Mononucleotide (NMN) Production Value Market Share by Region (2021–2026)
 Table 19. Global β-Nicotinamide Mononucleotide (NMN) Production Value (US$ Million) Forecast by Region (2027–2032)
 Table 20. Global β-Nicotinamide Mononucleotide (NMN) Production Value Market Share Forecast by Region (2027–2032)
 Table 21. Global β-Nicotinamide Mononucleotide (NMN) Production Comparison by Region: 2021 vs 2025 vs 2032 (Tons)
 Table 22. Global β-Nicotinamide Mononucleotide (NMN) Production (Tons) by Region (2021–2026)
 Table 23. Global β-Nicotinamide Mononucleotide (NMN) Production Market Share by Region (2021–2026)
 Table 24. Global β-Nicotinamide Mononucleotide (NMN) Production (Tons) Forecast by Region (2027–2032)
 Table 25. Global β-Nicotinamide Mononucleotide (NMN) Production Market Share Forecast by Region (2027–2032)
 Table 26. Global β-Nicotinamide Mononucleotide (NMN) Market Average Price (US$/Kg) by Region (2021–2026)
 Table 27. Global β-Nicotinamide Mononucleotide (NMN) Market Average Price (US$/Kg) by Region (2027–2032)
 Table 28. Global β-Nicotinamide Mononucleotide (NMN) Consumption Growth Rate by Region: 2021 vs 2025 vs 2032 (Tons)
 Table 29. Global β-Nicotinamide Mononucleotide (NMN) Consumption by Region (Tons), 2021–2026
 Table 30. Global β-Nicotinamide Mononucleotide (NMN) Consumption Market Share by Region (2021–2026)
 Table 31. Global β-Nicotinamide Mononucleotide (NMN) Forecasted Consumption by Region (Tons), 2027–2032
 Table 32. Global β-Nicotinamide Mononucleotide (NMN) Forecasted Consumption Market Share by Region (2027–2032)
 Table 33. North America β-Nicotinamide Mononucleotide (NMN) Consumption Growth Rate by Country: 2021 vs 2025 vs 2032 (Tons)
 Table 34. North America β-Nicotinamide Mononucleotide (NMN) Consumption by Country (Tons), 2021–2026
 Table 35. North America β-Nicotinamide Mononucleotide (NMN) Consumption by Country (Tons), 2027–2032
 Table 36. Europe β-Nicotinamide Mononucleotide (NMN) Consumption Growth Rate by Country: 2021 vs 2025 vs 2032 (Tons)
 Table 37. Europe β-Nicotinamide Mononucleotide (NMN) Consumption by Country (Tons), 2021–2026
 Table 38. Europe β-Nicotinamide Mononucleotide (NMN) Consumption by Country (Tons), 2027–2032
 Table 39. Asia Pacific β-Nicotinamide Mononucleotide (NMN) Consumption Growth Rate by Region: 2021 vs 2025 vs 2032 (Tons)
 Table 40. Asia Pacific β-Nicotinamide Mononucleotide (NMN) Consumption by Region (Tons), 2021–2026
 Table 41. Asia Pacific β-Nicotinamide Mononucleotide (NMN) Consumption by Region (Tons), 2027–2032
 Table 42. Latin America, Middle East & Africa β-Nicotinamide Mononucleotide (NMN) Consumption Growth Rate by Country: 2021 vs 2025 vs 2032 (Tons)
 Table 43. Latin America, Middle East & Africa β-Nicotinamide Mononucleotide (NMN) Consumption by Country (Tons), 2021–2026
 Table 44. Latin America, Middle East & Africa β-Nicotinamide Mononucleotide (NMN) Consumption by Country (Tons), 2027–2032
 Table 45. Global β-Nicotinamide Mononucleotide (NMN) Production (Tons) by Type (2021–2026)
 Table 46. Global β-Nicotinamide Mononucleotide (NMN) Production (Tons) by Type (2027–2032)
 Table 47. Global β-Nicotinamide Mononucleotide (NMN) Production Market Share by Type (2021–2026)
 Table 48. Global β-Nicotinamide Mononucleotide (NMN) Production Market Share by Type (2027–2032)
 Table 49. Global β-Nicotinamide Mononucleotide (NMN) Production Value (US$ Million) by Type (2021–2026)
 Table 50. Global β-Nicotinamide Mononucleotide (NMN) Production Value (US$ Million) by Type (2027–2032)
 Table 51. Global β-Nicotinamide Mononucleotide (NMN) Production Value Market Share by Type (2021–2026)
 Table 52. Global β-Nicotinamide Mononucleotide (NMN) Production Value Market Share by Type (2027–2032)
 Table 53. Global β-Nicotinamide Mononucleotide (NMN) Price (US$/Kg) by Type (2021–2026)
 Table 54. Global β-Nicotinamide Mononucleotide (NMN) Price (US$/Kg) by Type (2027–2032)
 Table 55. Global β-Nicotinamide Mononucleotide (NMN) Production (Tons) by Application (2021–2026)
 Table 56. Global β-Nicotinamide Mononucleotide (NMN) Production (Tons) by Application (2027–2032)
 Table 57. Global β-Nicotinamide Mononucleotide (NMN) Production Market Share by Application (2021–2026)
 Table 58. Global β-Nicotinamide Mononucleotide (NMN) Production Market Share by Application (2027–2032)
 Table 59. Global β-Nicotinamide Mononucleotide (NMN) Production Value (US$ Million) by Application (2021–2026)
 Table 60. Global β-Nicotinamide Mononucleotide (NMN) Production Value (US$ Million) by Application (2027–2032)
 Table 61. Global β-Nicotinamide Mononucleotide (NMN) Production Value Market Share by Application (2021–2026)
 Table 62. Global β-Nicotinamide Mononucleotide (NMN) Production Value Market Share by Application (2027–2032)
 Table 63. Global β-Nicotinamide Mononucleotide (NMN) Price (US$/Kg) by Application (2021–2026)
 Table 64. Global β-Nicotinamide Mononucleotide (NMN) Price (US$/Kg) by Application (2027–2032)
 Table 65. GeneHarbor β-Nicotinamide Mononucleotide (NMN) Company Information
 Table 66. GeneHarbor β-Nicotinamide Mononucleotide (NMN) Specification and Application
 Table 67. GeneHarbor β-Nicotinamide Mononucleotide (NMN) Production (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021–2026)
 Table 68. GeneHarbor Main Business and Markets Served
 Table 69. GeneHarbor Recent Developments/Updates
 Table 70. Herbalmax β-Nicotinamide Mononucleotide (NMN) Company Information
 Table 71. Herbalmax β-Nicotinamide Mononucleotide (NMN) Specification and Application
 Table 72. Herbalmax β-Nicotinamide Mononucleotide (NMN) Production (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021–2026)
 Table 73. Herbalmax Main Business and Markets Served
 Table 74. Herbalmax Recent Developments/Updates
 Table 75. Genex Formulas β-Nicotinamide Mononucleotide (NMN) Company Information
 Table 76. Genex Formulas β-Nicotinamide Mononucleotide (NMN) Specification and Application
 Table 77. Genex Formulas β-Nicotinamide Mononucleotide (NMN) Production (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021–2026)
 Table 78. Genex Formulas Main Business and Markets Served
 Table 79. Genex Formulas Recent Developments/Updates
 Table 80. Mirailab Bioscience β-Nicotinamide Mononucleotide (NMN) Company Information
 Table 81. Mirailab Bioscience β-Nicotinamide Mononucleotide (NMN) Specification and Application
 Table 82. Mirailab Bioscience β-Nicotinamide Mononucleotide (NMN) Production (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021–2026)
 Table 83. Mirailab Bioscience Main Business and Markets Served
 Table 84. Mirailab Bioscience Recent Developments/Updates
 Table 85. Maac10 Formulas β-Nicotinamide Mononucleotide (NMN) Company Information
 Table 86. Maac10 Formulas β-Nicotinamide Mononucleotide (NMN) Specification and Application
 Table 87. Maac10 Formulas β-Nicotinamide Mononucleotide (NMN) Production (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021–2026)
 Table 88. Maac10 Formulas Main Business and Markets Served
 Table 89. Maac10 Formulas Recent Developments/Updates
 Table 90. EffePharm β-Nicotinamide Mononucleotide (NMN) Company Information
 Table 91. EffePharm β-Nicotinamide Mononucleotide (NMN) Specification and Application
 Table 92. EffePharm β-Nicotinamide Mononucleotide (NMN) Production (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021–2026)
 Table 93. EffePharm Main Business and Markets Served
 Table 94. EffePharm Recent Developments/Updates
 Table 95. Bontac β-Nicotinamide Mononucleotide (NMN) Company Information
 Table 96. Bontac β-Nicotinamide Mononucleotide (NMN) Specification and Application
 Table 97. Bontac β-Nicotinamide Mononucleotide (NMN) Production (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021–2026)
 Table 98. Bontac Main Business and Markets Served
 Table 99. Bontac Recent Developments/Updates
 Table 100. CELFULL β-Nicotinamide Mononucleotide (NMN) Company Information
 Table 101. CELFULL β-Nicotinamide Mononucleotide (NMN) Specification and Application
 Table 102. CELFULL β-Nicotinamide Mononucleotide (NMN) Production (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021–2026)
 Table 103. CELFULL Main Business and Markets Served
 Table 104. CELFULL Recent Developments/Updates
 Table 105. Kingdomway β-Nicotinamide Mononucleotide (NMN) Company Information
 Table 106. Kingdomway β-Nicotinamide Mononucleotide (NMN) Specification and Application
 Table 107. Kingdomway β-Nicotinamide Mononucleotide (NMN) Production (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021–2026)
 Table 108. Kingdomway Main Business and Markets Served
 Table 109. Kingdomway Recent Developments/Updates
 Table 110. ABA Chemical β-Nicotinamide Mononucleotide (NMN) Company Information
 Table 111. ABA Chemical β-Nicotinamide Mononucleotide (NMN) Specification and Application
 Table 112. ABA Chemical β-Nicotinamide Mononucleotide (NMN) Production (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021–2026)
 Table 113. ABA Chemical Main Business and Markets Served
 Table 114. ABA Chemical Recent Developments/Updates
 Table 115. Key Raw Materials Lists
 Table 116. Raw Materials Key Suppliers Lists
 Table 117. β-Nicotinamide Mononucleotide (NMN) Distributors List
 Table 118. β-Nicotinamide Mononucleotide (NMN) Customers List
 Table 119. β-Nicotinamide Mononucleotide (NMN) Market Trends
 Table 120. β-Nicotinamide Mononucleotide (NMN) Market Drivers
 Table 121. β-Nicotinamide Mononucleotide (NMN) Market Challenges
 Table 122. β-Nicotinamide Mononucleotide (NMN) Market Restraints
 Table 123. Research Programs/Design for This Report
 Table 124. Key Data Information from Secondary Sources
 Table 125. Key Data Information from Primary Sources
 Table 126. Authors List of This Report


List of Figures
 Figure 1. Product Picture of β-Nicotinamide Mononucleotide (NMN)
 Figure 2. Global β-Nicotinamide Mononucleotide (NMN) Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global β-Nicotinamide Mononucleotide (NMN) Market Share by Type: 2025 vs 2032
 Figure 4. Content ≥98% Product Picture
 Figure 5. Content <98% Product Picture
 Figure 6. Global β-Nicotinamide Mononucleotide (NMN) Market Value by Application (US$ Million), 2021–2032
 Figure 7. Global β-Nicotinamide Mononucleotide (NMN) Market Share by Application: 2025 vs 2032
 Figure 8. Health Care Products
 Figure 9. Cosmetics
 Figure 10. Others
 Figure 11. Global β-Nicotinamide Mononucleotide (NMN) Production Value (US$ Million), 2021 vs 2025 vs 2032
 Figure 12. Global β-Nicotinamide Mononucleotide (NMN) Production Value (US$ Million), 2021–2032
 Figure 13. Global β-Nicotinamide Mononucleotide (NMN) Production Capacity (Tons), 2021–2032
 Figure 14. Global β-Nicotinamide Mononucleotide (NMN) Production (Tons), 2021–2032
 Figure 15. Global β-Nicotinamide Mononucleotide (NMN) Average Price (US$/Kg), 2021–2032
 Figure 16. β-Nicotinamide Mononucleotide (NMN) Report Years Considered
 Figure 17. β-Nicotinamide Mononucleotide (NMN) Production Share by Manufacturers in 2025
 Figure 18. Global β-Nicotinamide Mononucleotide (NMN) Production Value Share by Manufacturers (2025)
 Figure 19. β-Nicotinamide Mononucleotide (NMN) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 20. Top 5 and Top 10 Global Players: Market Share by β-Nicotinamide Mononucleotide (NMN) Revenue in 2025
 Figure 21. Global β-Nicotinamide Mononucleotide (NMN) Production Value by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Figure 22. Global β-Nicotinamide Mononucleotide (NMN) Production Value Market Share by Region: 2021 vs 2025 vs 2032
 Figure 23. Global β-Nicotinamide Mononucleotide (NMN) Production Comparison by Region: 2021 vs 2025 vs 2032 (Tons)
 Figure 24. Global β-Nicotinamide Mononucleotide (NMN) Production Market Share by Region: 2021 vs 2025 vs 2032
 Figure 25. North America β-Nicotinamide Mononucleotide (NMN) Production Value (US$ Million) Growth Rate (2021–2032)
 Figure 26. China β-Nicotinamide Mononucleotide (NMN) Production Value (US$ Million) Growth Rate (2021–2032)
 Figure 27. Japan β-Nicotinamide Mononucleotide (NMN) Production Value (US$ Million) Growth Rate (2021–2032)
 Figure 28. Global β-Nicotinamide Mononucleotide (NMN) Consumption by Region: 2021 vs 2025 vs 2032 (Tons)
 Figure 29. Global β-Nicotinamide Mononucleotide (NMN) Consumption Market Share by Region: 2021 vs 2025 vs 2032
 Figure 30. North America β-Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (Tons), 2021–2032
 Figure 31. North America β-Nicotinamide Mononucleotide (NMN) Consumption Market Share by Country (2021–2032)
 Figure 32. U.S. β-Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (Tons), 2021–2032
 Figure 33. Canada β-Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (Tons), 2021–2032
 Figure 34. Europe β-Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (Tons), 2021–2032
 Figure 35. Europe β-Nicotinamide Mononucleotide (NMN) Consumption Market Share by Country (2021–2032)
 Figure 36. Germany β-Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (Tons), 2021–2032
 Figure 37. France β-Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (Tons), 2021–2032
 Figure 38. U.K. β-Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (Tons), 2021–2032
 Figure 39. Italy β-Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (Tons), 2021–2032
 Figure 40. Russia β-Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (Tons), 2021–2032
 Figure 41. Asia Pacific β-Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (Tons), 2021–2032
 Figure 42. Asia Pacific β-Nicotinamide Mononucleotide (NMN) Consumption Market Share by Region (2021–2032)
 Figure 43. China β-Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (Tons), 2021–2032
 Figure 44. Japan β-Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (Tons), 2021–2032
 Figure 45. South Korea β-Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (Tons), 2021–2032
 Figure 46. China Taiwan β-Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (Tons), 2021–2032
 Figure 47. Southeast Asia β-Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (Tons), 2021–2032
 Figure 48. India β-Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (Tons), 2021–2032
 Figure 49. Latin America, Middle East & Africa β-Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (Tons), 2021–2032
 Figure 50. Latin America, Middle East & Africa β-Nicotinamide Mononucleotide (NMN) Consumption Market Share by Country (2021–2032)
 Figure 51. Mexico β-Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (Tons), 2021–2032
 Figure 52. Brazil β-Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (Tons), 2021–2032
 Figure 53. Turkey β-Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (Tons), 2021–2032
 Figure 54. GCC Countries β-Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (Tons), 2021–2032
 Figure 55. Global Production Market Share of β-Nicotinamide Mononucleotide (NMN) by Type (2021–2032)
 Figure 56. Global Production Value Market Share of β-Nicotinamide Mononucleotide (NMN) by Type (2021–2032)
 Figure 57. Global β-Nicotinamide Mononucleotide (NMN) Price (US$/Kg) by Type (2021–2032)
 Figure 58. Global Production Market Share of β-Nicotinamide Mononucleotide (NMN) by Application (2021–2032)
 Figure 59. Global Production Value Market Share of β-Nicotinamide Mononucleotide (NMN) by Application (2021–2032)
 Figure 60. Global β-Nicotinamide Mononucleotide (NMN) Price (US$/Kg) by Application (2021–2032)
 Figure 61. β-Nicotinamide Mononucleotide (NMN) Value Chain
 Figure 62. Channels of Distribution (Direct Vs Distribution)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Lukasiewicz Research Network